ReviewDiagnostics (Basel, Switzerland)2026
Post-CDK4/6 Inhibitor Therapeutic Approaches in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Current Evidence and Emerging Strategies-A Narrative Review.
Humaid O Al-Shamsi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.